| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1285964 |
Fluvastatin Related Compound B (15 mg) ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester) |
129332-29-2 |
|
| 2933997500 |
|
|
|
| USP-1285986 |
Flutamide Related Compound B (20 mg) (N-[4-nitro-3-(trifluoromethyl)phenyl]acetamide) |
393-12-4 |
UN3261 |
| USP-1285997 |
Flutamide Related Compound A (20 mg) (4-nitro-3-(trifluoromethyl)aniline) |
393-11-3 |
|
| 2924296000 |
|
|
|
| USP-1286005 |
Folic Acid (500 mg) (Vitamin M or Vitamin Bc) |
59-30-3 |
|
| 2936291000 |
|
|
|
| USP-1286027 |
Folic Acid Related Compound A (50 mg) (Calcium Formyltetrahydrofolate) |
1492-18-8 |
|
| 2936299055 |
|
|
|
| USP-1286060 |
Formononetin (50 mg) |
485-72-3 |
|
| 2932996560 |
|
|
|
| USP-1286107 |
Formoterol Fumarate (200 mg) |
183814-30-4 |
UN2811 |
| USP-1286141 |
Formoterol Related Compound D (30 mg) (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl](methyl)amino}ethyl)phenyl)formamide fumarate) |
1795133-97-9 |
|
| 2924296000 |
|
|
|
| USP-1286184 |
Formoterol Related Compound I (25 mg) (N-(2-hydroxy-5-[(RS)-1-hydroxy-2-{[(SR)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl)formamide) |
532414-36-1 |
|
| 2924296000 |
|
|
|
| USP-1286209 |
Mafenide Related Compound A (50 mg) (4-Formylbenzenesulfonamide) |
3240-35-5 |
|
| 2935909550 |
|
|
|
| USP-1286300 |
10-Formylfolic Acid (25 mg) (L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]formylamino-]benzoyl]-) |
134-05-4 |
|
| 2936299055 |
|
|
|
| USP-1286311 |
Formyl Penicillamine (25 mg) (2-Formamido-3-mercapto-3-methylbutanoic acid) |
158411-82-6 |
|
| 2930909265 |
|
|
|
| USP-1286322 |
Fosfomycin Tromethamine (800 mg) |
78964-85-9 |
|
| 2941906000 |
|
|
|
| USP-1286366 |
Fosphenytoin Sodium (350 mg) |
2214317-48-1 |
|
| 2933290000 |
|
|
|
| USP-1286402 |
Frovatriptan Racemate (15 mg) |
147009-08-3 |
|
| 2933995500 |
|
|
|
| USP-1296010 |
Glycopyrrolate Erythro Isomer (25 mg) ((RS)-3-[(RS)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1296029 |
Glycopyrrolate Related Compound A (50 mg) (5-Nitrobenzene-1,3-dicarboxylic acid) |
618-88-2 |
|
| 2917394000 |
|
|
|
| USP-1296031 |
Glycopyrrolate Related Compound B (50 mg) (1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Hydrochloride) |
13118-10-0 |
|
| 2917394000 |
|
|
|
| USP-1296042 |
Glycopyrrolate Related Compound C (25 mg) (2-Cyclopentyl-2-hydroxy-2-phenylacetic acid) |
427-49-6 |
|
| 2918195000 |
|
|
|
| USP-1296086 |
Glycopyrrolate Related Compound I (15 mg) ((RS)-3-[(SR)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1296701 |
[D-His2]-Gonadorelin (1 mg) (5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosylglycyl-L-leucyl-L-arginyl-L-prolylglycinamide) |
53634-19-8 |
|
| 2933998350 |
|
|
|
| USP-1296712 |
[D-Tyr5]-Gonadorelin (1 mg) (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-D-tyrosylglycyl-L-leucyl-L-arginyl-L-prolylglycinamide) |
53634-21-2 |
|
| 2933998350 |
|
|
|
| USP-1297205 |
Goserelin Acetate (100 mg) (需冷链运输) |
145781-92-6 |
|
| 2937190000 |
|
|
|
| USP-1297216 |
Goserelin Related Compound A (10 mg) (4-D-Serine Goserelin, 1-(5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-L-prolyl) semicarbazide) (需冷链运输) |
1926163-39-4 |
|
| 2933790002 |
|
|
|
| USP-1096586 |
Carglumic Acid (200 mg) |
1188-38-1 |
|
| 2924190002 |
|
|
|
| USP-1096597 |
Carisoprodol Related Compound A (10 mg) (2-hydroxymethyl-2-methylpentyl carbamate) |
1471-56-3 |
|
| 2924190002 |
|
|
|
| USP-1096611 |
Carmellose (500 mg) |
9000/11/7 |
|
| 3912310000 |
|
|
|
| USP-1096622 |
Carvedilol (200 mg) |
72956-09-3 |
UN3077 |
| USP-1096633 |
Carvedilol Related Compound A (15 mg) (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol) |
1198090-73-1 |
|
| 2933997500 |
|
|
|
| USP-1096644 |
Carvedilol Related Compound B (15 mg) (3,3′-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol)) |
918903-20-5 |
|
| 2933998350 |
|
|
|
| USP-1096655 |
Carvedilol Related Compound C (20 mg) (1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol) |
72955-94-3 |
|
| 2933997500 |
|
|
|
| USP-1096666 |
Carvedilol Related Compound D (15 mg) (4-(Oxiran-2-ylmethoxy)-9H-carbazole) |
51997-51-4 |
|
| 2933997500 |
|
|
|
| USP-1096677 |
Carvedilol Related Compound E (15 mg) (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate) |
2057412-43-6 |
|
| 2922504500 |
|
|
|
| USP-1096688 |
Carvedilol System Suitability Mixture (25 mg) (carvedilol spiked with carvedilol related compound F) |
N/A |
UN3077 |
| USP-1096699 |
Carprofen (200 mg) |
53716-49-7 |
UN2811 |
| USP-1096724 |
Carmustine (75 mg) (需冷链运输) |
154-93-8 |
UN2811 |
| USP-1096735 |
Carmustine Related Compound A (25 mg) (1,3-bis(2-chloroethyl)urea) |
2214-72-4 |
|
| 2924190002 |
|
|
|
| USP-1096746 |
Carnosic acid (20 mg) |
3650/9/7 |
|
| 2918195000 |
|
|
|
| USP-1096757 |
Carteolol Hydrochloride (200 mg) |
51781-21-6 |
|
| 2933790002 |
|
|
|
| USP-1134084 |
Ciclopirox Related Compound C (10 mg) (6-Cyclohexyl-4-methylpyridin-2(1H)-one) |
67587-24-0 |
|
| 2934990005 |
|
|
|
| USP-1134120 |
Cisapride (200 mg) |
260779-88-2 |
|
| 2933399095 |
|
|
|
| USP-1134131 |
Cisatracurium Besylate System Suitability Mixture (20 mg) |
N/A |
UN2811 |
| USP-1134142 |
R-Citalopram Oxalate (10 mg) ((R)-1-[3-(Dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate) |
219861-53-7 |
|
| 2932996560 |
|
|
|
| USP-1134153 |
Cilostazol (200 mg) |
73963-72-1 |
|
| 2933790002 |
|
|
|
| USP-1134164 |
Cilostazol Related Compound A (50 mg) (6-hydroxy-3,4-dihydro-1H-quinolin-2-one) |
54197-66-9 |
|
| 2933790002 |
|
|
|
| USP-1134175 |
Cilostazol Related Compound B (50 mg) (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one) |
73963-62-9 |
|
| 2933790002 |
|
|
|
| USP-1134186 |
Cilostazol Related Compound C (50 mg) (1-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) |
865792-18-3 |
|
| 2933790002 |
|
|
|
| USP-1134197 |
Citalopram Related Compound G (25 mg) (1-(4′-fluorophenyl)-1-(3-dimethylaminopropyl)-5-chlorophthalane hydrobromide) |
N/A |
|
| 2932996560 |
|
|
|
| USP-1134200 |
Cladribine (200 mg) |
4291-63-8 |
|
| 2934990005 |
|
|
|
| USP-1134211 |
Cladribine Related Compound A (20 mg) (2-methoxy-2′-deoxyadenosine) |
24757-70-8 |
|
| 2934990005 |
|
|
|
| USP-1134222 |
Citalopram Related Compound H (25 mg) (1-(4′-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide) |
479065-02-6 |
|
| 2932996560 |
|
|
|
| USP-1134233 |
Citalopram Hydrobromide (200 mg) |
59729-32-7 |
UN3077 |
| USP-1134244 |
Citalopram Related Compound A (25 mg) (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide) |
64372-56-1 |
|
| 2932996560 |
|
|
|
| USP-1134255 |
Citalopram Related Compound B (25 mg) (1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5-carbonitrile oxalate) |
1332724-03-4 |
|
| 2932996560 |
|
|
|
| USP-1134266 |
Citalopram Related Compound C (25 mg) (3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate) |
1440961-11-4 |
|
| 2932206000 |
|
|
|
| USP-1134277 |
Citalopram Related Compound D (15 mg) (1-(4-Fluorophenyl)-1-(3-methylaminopropyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrochloride) |
97743-99-2 |
|
| 2932996560 |
|
|
|
| USP-1370779 |
Lufenuron (200 mg) |
103055-07-8 |
UN3077 |
| USP-1370780 |
Lufenuron Related Compound G (15 mg) (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate) |
N/A |
UN3077 |
| USP-1370837 |
Luteolin 7-O-Glucoside (30 mg) (2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside) |
5373/11/5 |
|
| 2938900000 |
|
|
|
| USP-1370881 |
Lycopene Preparation (500 mg) |
502-65-8 |
|
| 3203000000 |
|
|
|
| USP-1370906 |
Lynestrenol (20 mg) ((17alpha) -19-Norpregn-4-en-20-yn-17-ol) |
52-76-6 |
|
| 2937230000 |
|
|
|
| USP-1371501 |
L-Lysine Acetate (200 mg) |
57282-49-2 |
|
| 2922410000 |
|
|
|
| USP-1372005 |
L-Lysine Hydrochloride (200 mg) |
657-27-2 |
|
| 2922410000 |
|
|
|
| USP-1372344 |
Polyamide 6 (1 g) |
25038-54-4 |
|
| 3908100000 |
|
|
|
| USP-1372435 |
Polyoxyl 9 Lauryl Ether (1 g) (Polyethylene glycol monolauryl ether (n=9)) |
9002-92-0 |
UN3082 |
| USP-1372468 |
Polyoxyl 23 Lauryl Ether (0.5 g) |
9002-92-0 |
UN3082 |
| USP-1372606 |
Polyoxyl 10 Stearyl Ether (1 g) |
9005-00-9 |
|
| 3907290000 |
|
|
|
| USP-1373008 |
Mafenide Acetate (200 mg) |
13009-99-9 |
|
| 2935904000 |
|
|
|
| USP-1380579 |
Memantine Related Compound G (30 mg) (3-Methyladamantan-1-amine hydrochloride) |
33103-93-4 |
|
| 2921300000 |
|
|
|
| USP-1380580 |
Memantine Related Compound H (30 mg) (3,5,7-Trimethyladamantan-1-amine hydrochloride) |
15210-60-3 |
|
| 2921300000 |
|
|
|
| USP-1380591 |
Memantine Related Compound I (30 mg) (3-Ethyladamantan-1-amine hydrochloride) |
80121-67-1 |
|
| 2921300000 |
|
|
|
| USP-1381006 |
Menadione (200 mg) |
58-27-5 |
UN3077 |
| USP-1381083 |
Menaquinone-4 (50 mg) (2-Methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthalene-1,4-dione) (需冷链运输) |
863-61-6 |
|
| 2914699000 |
|
|
|
| USP-1381709 |
Menthol (250 mg) |
2216-51-5 |
|
| 2906110000 |
|
|
|
| USP-1387002 |
Mepivacaine Hydrochloride (200 mg) |
1722-62-9 |
UN2811 |
| USP-1391000 |
3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt (75 mg) |
N/A |
|
| 2921490002 |
|
|
|
| USP-1392002 |
Mercaptopurine (500 mg) |
6112-76-1 |
|
| 2933595960 |
|
|
|
| USP-1392454 |
Meropenem (300 mg) |
119478-56-7 |
|
| 2941906000 |
|
|
|
| USP-1392705 |
Mesalamine (200 mg) |
89-57-6 |
|
| 2922504500 |
|
|
|
| USP-1392807 |
Mesna (200 mg) |
19767-45-4 |
|
| 2930909265 |
|
|
|
| USP-1392818 |
Mesna Related Compound A (50 mg) (2-(Acetylthio)ethane-1-sulfonic acid, potassium salt, crystal adduct with potassium chloride) |
N/A |
|
| 2930909265 |
|
|
|
| USP-1392829 |
Mesna Related Compound B (50 mg) (2,2′-Disulfanediylbis(ethane-1-sulfonic acid), dipotassium salt, crystal adduct with sodium chloride) |
N/A |
|
| 2930909265 |
|
|
|
| USP-1393005 |
Mesoridazine Besylate (25 mg) |
32672-69-8 |
|
| 2934302300 |
|
|
|
| USP-1394008 |
Mestranol (200 mg) |
72-33-3 |
|
| 2937230000 |
|
|
|
| USP-1606060 |
Rotigotine (50 mg) ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol) |
99755-59-6 |
UN3077 |
| USP-1606079 |
Rotigotine Hydrochloride (300 mg) ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) |
125572-93-2 |
UN3077 |
| USP-1606081 |
Rotigotine Racemate (25 mg) ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) |
102120-99-0 |
UN3077 |
| USP-1614578 |
Sodium Picosulfate (50 mg) |
10040-45-6 |
|
| 2933399095 |
|
|
|
| USP-1614603 |
Sodium Propionate (200 mg) |
137-40-6 |
|
| 2915503000 |
|
|
|
| USP-1614636 |
Sodium Salicylate (500 mg) |
54-21-7 |
|
| 2918211000 |
|
|
|
